$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Methods for treatment of severe acute respiratory syndrome (SARS) 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/215
출원번호 US-0441059 (2003-05-20)
등록번호 US7892563 (2011-02-08)
발명자 / 주소
  • Siber, George R.
출원인 / 주소
  • Wyeth Holdings Corporation
대리인 / 주소
    Hunton & Williams LLP
인용정보 피인용 횟수 : 0  인용 특허 : 32

초록

Compositions and methods for treating Severe Acute Respiratory Syndrome (SARS) are disclosed herein. Inhibitors of SARS-associated inflammatory cytokines are provided herein for use in treating SARS, including SARS-associated coronavirus (SARS-CoV) infection. Inhibitors of TNF are disclosed herein,

대표청구항

What is claimed is: 1. A method for treating a patient having Severe Acute Respiratory Syndrome (SARS) comprising:administering to the patient a therapeutically effective amount of a medicament comprising an inhibitor of TNF and a pharmaceutically acceptable carrier thereof, wherein the medicament i

이 특허에 인용된 특허 (32)

  1. Le Junming ; Vilcek Jan ; Daddona Peter ; Ghrayeb John ; Knight David ; Siegel Scott, Anti-TNF antibodies and peptides of human tumor necrosis factor.
  2. Baker Brenda F. ; Bennett C. Frank ; Butler Madeline M. ; Shanahan ; Jr. William R., Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (TNF-.alpha.) expression.
  3. Piscopio Anthony ; Rizzi James P., Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors.
  4. Robinson Ralph P. ; Rizzi James P., Arylsulfonylamino hydroxamic acid derivatives.
  5. Cohan Victoria L. (Groton CT) Duplantier Allen J. (Ledyard CT), Catechol diether compounds as inhibitors of TNF release.
  6. Gombotz Wayne R. ; Wee SiowFong, Controlled release polypeptide compositions and methods of treating inflammatory bowel disease.
  7. Burgess Laurence E. ; Rizzi James P. ; Rawson David J.,GBX, Cyclic sulfone derivatives.
  8. Smith Craig A. ; Goodwin Raymond G. ; Beckmann M. Patricia, DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors.
  9. Smith Craig A. (Seattle WA) Goodwin Raymond G. (Seattle WA) Beckmann M. Patricia (Poulsbo WA), DNA encoding tumor necrosis factor-ab 상세보기
  • Duplantier Allen J. (New York NY), Dihydro pyrazolopyrroles.
  • Duplantier Allen J. (Ledyard CT), Dihydro pyrazolopyrroles, compositions and use.
  • Crimmin Michael John,GBX ; Beckett Raymond Paul,GBX, Hydroxamic acid derivatives as inhibitors of cytokine production.
  • David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  • Crimmin Michael John (Cowley GB3) Galloway William Alan (Cowley GB3) Gearing Andrew John Hubert (Cowley GB3), Inhibition of TNF production with matrix metaloproteinase inhibitors.
  • Black Roy A. (Seattle WA) Fitzner Jeffrey N. (Seattle WA) Sleath Paul R. (Seattle WA), Inhibitors of TNF-a 상세보기
  • Baxter Andrew Douglas,GBX ; Montana John Gary,GBX ; Owen David Alan,GBX, Mercapto alkyl peptidyl compounds having MMP and TNF inhibitory activity.
  • Beckett Raymond Paul,GBX ; Whittaker Mark,GBX ; Miller Andrew,GBX ; Martin Fionna Mitchell,GBX, Metalloproteinase inhibitors.
  • Mandell Gerald L. (Earlysville VA) Sullivan Gail W. (Charlottesville VA) Novick William J. (Lebanon NJ), Method of inhibiting the activity of leukocyte derived cytokines.
  • Mandell Gerald L. (Earlysville VA) Sullivan Gail W. (Charlottesville VA) Novick William J. (Lebanon NJ), Method of inhibiting the activity of leukocyte derived cytokines.
  • Goldstein Neil I. (New Brunswick NJ), Method of producing monoclonal anti-idiotype antibody.
  • Jacobs Cindy A. (Seattle WA) Smith Craig A. (Seattle WA), Methods of lowering active TNF-a 상세보기
  • Monia Brett P. ; Xu Xiaoxing S., Methods of modulating tumor necrosis factor .alpha.-induced expression of cell adhesion molecules.
  • Le Junming (Jackson Heights NY) Vilcek Jan (New York NY) Dadonna Peter (Palo Alto CA) Ghrayeb John (Thorndale PA) Knight David (Berwyn PA) Siegel Scott A. (Westborough MA), Methods of treating TNF-a 상세보기
  • Rathjen Deborah A.,AUX ; Widmer Fred,AUX ; Grigg Geoffrey W.,AUX ; Mack Philip O.,AUX, Peptide which abrogates TNF and/or LPS toxicity.
  • Wallach David,ILX ; Kost Josef,ILX ; Eliaz Rom,ILX, Pharmaceutical compositions for controlled release of soluble receptors.
  • Hnel Heinz (Oberursel DEX) Schrinner Elmar (Wiesbaden DEX), Pharmaceutical containing TNF inhibitor.
  • Dyke Hazel Joan,GBX ; Montana John Gary,GBX, Quinoline sulfonamides and their therapeutic use.
  • Eberle Josef (Munich DEX) Seibl Rudolf (Penzberg DEX) Kessler Christoph (Dorfen DEX) Konig Bernhard (Berg DEX), Reagents and kits for determining polymerase activity.
  • Christensen ; IV Siegfried B. (Philadelphia PA) Esser Klaus M. (Downingtown PA) Simon Philip L. (Randolph NJ), TNF inhibition.
  • Edward L. Tobinick, TNF modulators for treating neurological disorders associated with viral infection.
  • Norris James S. ; Clawson Gary A., Tissue-specific and target RNA-specific ribozymes.
  • Jameson Bradford A. ; Noe Mariadele, Tumor necrosis factor inhibitors.
  • 문의처: helpdesk@kisti.re.kr전화: 080-969-4114

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로